Quality-of-life considerations in treatment of unresectable, recurrent head and neck cancer

Expert Review of Anticancer Therapy

Volumn 10, Issue 3, 2010, Pages 345-352

  McLarnon, Claire ^a   Kulloo, Praneta ^a   Mehanna, Hisham ^b   Kelly, Charles ^a   Paleri, Vinidh ^c  

^a NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY HOSPITALS COVENTRY AND WARWICKSHIRE NHS TRUST   (United Kingdom)

^c FREEMAN HOSPITAL   (United Kingdom)

Author keywords

Head and neck cancer; Palliative care; Quality of death; Quality of life; Recurrent head and neck cancer; Unresectable head and neck cancer

Indexed keywords

ADVANCED CANCER; BONE NECROSIS; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ASSESSMENT TOOL; COGNITION; COMORBIDITY; DYSPHAGIA; FATIGUE; FIBROSIS; FISTULA; FOLLOW UP; FUNCTIONAL ASSESSMENT; HEAD AND NECK CANCER; HEALTH CARE UTILIZATION; HEALTH STATUS; HUMAN; MUCOSA INFLAMMATION; OUTCOME ASSESSMENT; PALLIATIVE THERAPY; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; QUESTIONNAIRE; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIOFREQUENCY ABLATION; REPEAT PROCEDURE; REVIEW; RISK ASSESSMENT; SCORING SYSTEM; SOCIAL BEHAVIOR; SURVIVAL RATE; SURVIVOR; SYMPTOM; XEROSTOMIA;

HEAD AND NECK NEOPLASMS; HUMANS; NEOPLASM RECURRENCE, LOCAL; PALLIATIVE CARE; QUALITY OF LIFE; TERMINAL CARE; TREATMENT OUTCOME;

EID: 77949431838     PISSN: 14737140     EISSN: 17448328     Source Type: Journal    
DOI: 10.1586/ERA.10.13     Document Type: Review

References (43)

1. Specenier P, Vermorken J. Recurrent head and neck cancer: current treatment and future prospects. Expert Rev. Anticancer Ther. 8(3), 375-391 (2008).
2. Hoffman HT, Porter K, Karnell LH et al. Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival. Laryngoscope 116(9 Pt 2 Suppl. 111), 1-13 (2006).
3. Carvalho AL, Nishimoto IN, Califano JA, Kowalski LP. Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database. Int. J. Cancer 114(5), 806-816 (2005).
4. Coatesworth AP, Tsikoudas A, MacLennan K. The cause of death in patients with head and neck squamous cell carcinoma. J. Laryngol. Otol. 116(4), 269-271 (2002).
5. Leon X, Hitt R, Constenla M et al. A retrospective analysis of the outcome of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck refractory to a platinum-based chemotherapy. Clin. Oncol. (R. Coll. Radiol.) 17(6), 418-424 (2005).
6. Jones AS. The untreated patient with squamous carcinoma of the head and neck. Am. J. Clin. Oncol. 18(4), 363-368 (1995).
7. Kao J, Garofalo MC, Milano MT, Chmura SJ, Citron JR, Haraf DJ. Reirradiation of recurrent and second primary head and neck malignancies: a comprehensive review. Cancer Treat. Rev. 29(1), 21-30 (2003).
8. Wibault P, Bensmaine MA, de Forni M et al. Intensive concomitant chemoradiotherapy in locally advanced unresectable squamous cell carcinoma of the head and neck: a Phase II study of radiotherapy with cisplatin and 7-week continuous infusional fluorouracil. J. Clin. Oncol. 14(4), 1192-1200 (1996).
9. Ohizumi Y, Tamai Y, Imamiya S, Akiba T. Complications following re-irradiation for head and neck cancer. Am. J. Otolaryngol. 23(4), 215-221 (2002).
10. Wilson IB, Cleary PD. Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. JAMA 273(1), 59-65 (1995).
11. Tschiesner U, Rogers SN, Harreus U, Berghaus A, Cieza A. Content comparison of quality of life questionnaires used in head and neck cancer based on the international classification of functioning, disability and health: a systematic review. Eur. Arch. Otorhinolaryngol. 265(6), 627-637 (2008).
12. Ringash J, Bezjak A. A structured review of quality of life instruments for head and neck cancer patients. Head Neck 23(3), 201-213 (2001).
13. Revicki D, Kaplan R. Relationship between psychometric and utility-based approaches to the measurement of health related quality of life. Qual. Life Res. 2(6), 477-487 (1993).
14. Jalukar V, Funk GF, Christensen AJ, Karnell LH, Moran PJ. Health states following head and neck cancer treatment: patient, health-care professional, and public perspectives. Head Neck 20(7), 600-608 (1998).
15. Bjordal K, de Graeff A, Fayers PM et al. A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients. EORTC Quality of Life group. Eur. J. Cancer 36(14), 1796 - 1807 (2000).
16. Guntinas-Lichius O, Rühlow S, Veelken F, Klussmann JP. Quality of life during first-line palliative chemotherapy for recurrent and metastatic head and neck cancer with weekly cisplatin and docetaxel. J. Cancer Res. Clin. Oncol. 135, 901-908 (2009).
17. Stewart JS, Cohen EE, Licitra L et al. Phase III study of gefitinib compared with intravenous methotrexate for recurrent squamous cell carcinoma of the head and neck. J. Clin. Oncol. 27(11), 1864-1871 (2009).
18. Vermorken JB, Mesia R, Rivera F et al. Platinum-based chemotherapy plus cetuximab in head and neck cancer. N. Engl. J. Med. 359(11), 1116-1127 (2008).
19. Goldstein DP, Hynds Karnell L, Christensen AJ, Funk GF. Health-related quality of life profiles based on survivorship status for head and neck cancer patients. Head Neck 29(3), 221-229 (2007).
20. Marur S, Forastiere AA. Head and neck cancer: changing epidemiology, diagnosis, and treatment. Mayo Clin. Proc. 83(4), 489-501 (2008).
21. Rivera F, Garcia-Castano A, Vega N, Vega-Villegas ME, Gutierrez-Sanz L. Cetuximab in metastatic or recurrent head and neck cancer: the EXTREME trial. Expert Rev. Anticancer Ther. 9(10), 1421-1428 (2009).
22. Mowry SE, Ho A, LoTempio MM, Sadeghi A, Blackwell KE, Wang MB. Quality of life in advanced oropharyngeal carcinoma after chemoradiation versus surgery and radiation. Laryngoscope 116(9), 1589-1593 (2006).
23. Corry J, Peters LJ, Costa ID et al. The 'QUAD SHOT' - a Phase II study of palliative radiotherapy for incurable head and neck cancer. Radiother. Oncol. 77(2), 137-142 (2005).
24. Porceddu SV, Rosser B, Burmeister BH et al. Hypofractionated radiotherapy for the palliation of advanced head and neck cancer in patients unsuitable for curative treatment - 'Hypo Trial'. Radiother. Oncol. 85(3), 456-462 (2007).
25. Al-Mamgani A, Tans L, Van Rooij PH, Noever I, Baatenburg de Jong RJ, Levendag PC. Hypofractionated radiotherapy denoted as the 'Christie scheme': an effective means of palliating patients with head and neck cancers not suitable for curative treatment. Acta Oncol. 48(4), 562-570 (2009).
26. Paleri V, Kelly C. Re-irradiation with concurrent chemotherapy in recurrent head and neck cancer: a decision analysis model based on a systematic review. Clin. Otolaryngol. 33, 331-337 (2008).
27. Goldstein D, Karnell L, Yao M, Chamberlin G, Nguyen T, Funk G. Outcomes following reirradiation of patients with head and neck cancer. Head Neck 30(6), 765-770 (2008).
28. Kasperts N, Slotman B, Leemans CR, Langendijk JA. A review on re-irradiation for recurrent and second primary head and neck cancer. Oral Oncol. 41(3), 225-243 (2005).
29. Creak AL, Harrington K, Nutting C. Treatment of recurrent head and neck cancer: re-irradiation or chemotherapy? Clin. Oncol. (R. Coll. Radiol.) 17(3), 138-147 (2005).
30. Spencer SA, Harris J, Wheeler RH et al. Final report of RTOG 9610, a multi-institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck. Head Neck 30(3), 281-288 (2008).
31. El-Deiry MW, Futran ND, McDowell JA, Weymuller EA Jr, Yueh B. Influences and predictors of long-term quality of life in head and neck cancer survivors. Arch. Otolaryngol. Head Neck Surg. 135(4), 380-384 (2009).
32. Terrell JE, Ronis DL, Fowler KE et al. Clinical predictors of quality of life in patients with head and neck cancer. Arch. Otolaryngol. Head Neck Surg. 130(4), 401-408 (2004).
33. Rogers SN, Thomson R, O'Toole P, Lowe D. Patients experience with long-term percutaneous endoscopic gastrostomy feeding following primary surgery for oral and oropharyngeal cancer. Oral Oncol. 43(5), 499-507 (2007).
34. Gurney TA, Eisele DW, Orloff LA, Wang SJ. Predictors of quality of life after treatment for oral cavity and oropharyngeal carcinoma. Otolaryngol. Head Neck Surg. 139(2), 262-267 (2008).
35. Owen R, Silver C, Ravikumar T, Brook A, Bello J, Breining D. Techniques for radiofrequency ablation of head and neck tumors. Arch. Otolaryngol. Head Neck Surg. 130(1), 52-56 (2004).
36. Brook A, Gold M, Miller T et al. CT-guided radiofrequency ablation in the palliative treatment of recurrent advanced head and neck malignancies. J. Vasc. Interv. Radiol. 19, 725-735 (2008).
37. D'Cruz A, Robinson M, Biel M. mTHPC-mediated photodynamic therapy in patients with advanced, incurable head and neck cancer: a multicenter study of 128 patients. Head Neck 26(3), 232-240 (2004).
38. Piccirillo JF, Tierney RM, Costas I, Grove L, Spitznagel EL Jr. Prognostic importance of comorbidity in a hospital-based cancer registry. JAMA 291(20), 2441-2447 (2004).
39. Yung KC, Piccirillo JF. The incidence and impact of comorbidity diagnosed after the onset of head and neck cancer. Arch. Otolaryngol. Head Neck Surg 134(10), 1045-1049 (2008).
40. Kelly C, Paleri V, Downs C. Deterioration in quality of life and depressive symptoms during radiation therapy for head and neck cancer. Otolaryngol. Head Neck Surg, 136, 108-111 (2007).
41. El-Deiry MW, Futran ND, McDowell JA, Weymuller EA Jr, Yueh B. Influences and predictors of long-term quality of life in head and neck cancer survivors. Arch. Otolaryngol. Head Neck Surg 135(4), 380-384 (2009).
42. Goldstein N, Genden E, Morrison R. Palliative care for patients with head and neck cancer. 'I would like a quick return to a normal lifestyle'. JAMA 299, 1818-1825 (2008).
43. Tschiesner U, Rogers S, Dietz A, Yueh B, Cieza A. Development of ICF core sets for head and neck cancer. Head Neck 32(2), 210-220 (2010).